75岁以上老年非瓣膜病心房颤动患者抗血栓治疗的应用现状  

Analysis of antithrombotic therapy in elderly patients with atrial fibrillation

作　　者：吴雪萍[1] 张丽[1] 张帷[1] 陈韦任[1] 

机构地区：[1]解放军总医院南楼心血管一科,北京100853

出　　处：《中华老年心脑血管病杂志》2007年第4期235-236,共2页Chinese Journal of Geriatric Heart,Brain and Vessel Diseases

摘　　要：目的对于我院〉75岁老年非瓣膜病心房颤动（房颤）患者抗血栓药物治疗的情况进行调查，了解用药现状。方法调查〉75岁非瓣膜病房颤患者125例，对其危险因素及抗血栓药物使用情况进行分析。结果125例患者中，合并多种危险因素者多见，其中应用华法林者只有30例（24．0％），应用阿司匹林者54例（43.2％），其他抗血小板药物29例（23．2％），未应用抗血栓药物12例（9．6％）。阿司匹林及其他抗血小板口服药剂量为每天75—100mg。结论〉75岁老年非瓣膜病房颤患者华法林应用率低，抗血小板药使用率高，但用药剂量偏小。Objective To analyse antithrombotic therapy in patients over 75-years old with atrial fibrillation. Methods 125 patients over 75-years old with atrial fibrillation without valvular disease were enrolled. The antithrombotic medicines and cardioembolic risk factors were registed and analysed. Results Most patients had more than 2 embolic risk factors. Of the total 125 patients, 30 were given warfarin, 54 were given aspirin, 29 took other anti-platelet medicines and 12 did not take any antithrombotic medicines. The dosages of aspirin and other anti-platelet medicines were 75-100 mg/d. Conclusions The rate of use of warfarin was low. Antiplatelet medicines were frequently used, but the dosage tended to be low.

关 键 词：心房颤动 血栓溶解疗法 华法林 阿司匹林 危险因素 

分 类 号：R541.75[医药卫生—心血管疾病]